BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA

Risultato della ricerca: Otherpeer review

Abstract

At present, a prospectively validated treatment for SMZLis lacking. Despite this fact, splenectomy is still deemed to be the bestchoice for patients requiring treatment. Nevertheless, the high fractionof patients achieving a clinical response following splenectomy eventually relapses or progresses
Lingua originaleEnglish
Numero di pagine1
Stato di pubblicazionePublished - 2010

Fingerprint Entra nei temi di ricerca di 'BENDAMUSTINE IN ASSOCIATION WITH RITUXIMAB AS SALVAGE THERAPY FOR SPLENIC MARGINAL ZONE LYMPHOMA'. Insieme formano una fingerprint unica.

Cita questo